Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
329.00    0.00 (0.00%)
Bid:
322.00
Ask:
336.00
Spread: 14.00 (4.348%)
Market Cap: £41.75m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Director dealing & appointment

29 May 2012 16:54

RNS Number : 3543E
BrainJuicer Group PLC
29 May 2012
 



 

 

 

 

Press Release

 29 May 2012

 

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Director Appointment and Director Dealing

 

BrainJuicer (AIM: BJU), a leading international online market research agency, announced on 23rd April 2012 that Simon Godfrey, a non-executive director of the Company, intends to retire from the board of directors by the end of September 2012.

 

He has been reducing his shareholding as a result, and the Company updates that Simon has today disposed of 10,000 shares at 308.50p per share. Following the above transaction, Simon currently holds 14,298 shares representing 0.1% of the voting rights of the Company.

 

As a replacement for Simon, the Board is appointing Graham Blashill (aged 65) as a non-executive director with effect from 1st July 2012. Graham has had a long career in sales and marketing of fast moving consumer goods. He joined W.D.& H.O. Wills (a division of Imperial Tobacco) in 1968, holding a number of marketing and trading roles, and becoming Managing Director Imperial Tobacco UK in 1995. In 2003 he was Regional Director for Western Europe, and in 2005 appointed Group Sales and Marketing Director responsible for Imperial Tobacco's global trading operations in over 160 countries. He served as a main board director of Imperial Tobacco Group plc, a leading FTSE 100 company, for six years before retiring in 2011.

 

Disclosures regarding Mr Blashill appointment, pursuant to AIM rules (Schedule 2 paragraph (g)), are set out below:

 

Directorships held within the last five years

 

·; Imperial Tobacco Group Plc

·; Imperial Tobacco Limited

·; Imperial Tobacco Overseas Holdings (3) Limited

·; Imperial Tobacco International Limited

·; Altadis S.A.U.

·; Skruf Snus AB

·; Societe Nationale D'explotation Industrielle Des Tabacs et Allumettes SAS (SEITA)

·; Imperial Tobacco Pension Trustees Limited

·; Tobacco Trade Benevolent Association

 

Current Directorships

 

·; Tobacco Pipe Makers and Tobacco Trade Benevolent Fund

 

There is no further information to be disclosed under AIM rules (Schedule 2 paragraph (g)) in respect of Mr Blashill's appointment.

 

The Company can be found at www.brainjuicer.com.

 

- Ends -

 

For further information, please contact:

BrainJuicer Group PLC

 

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000

 

James Geddes, Chief Financial Officer

www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor

Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGZKKLFGZZM
Date   Source Headline
31st Aug 202211:00 amRNSNotice of AGM
31st Aug 20227:00 amRNSDirectorate Change
31st Aug 20227:00 amRNSReview of strategic options
30th Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20228:55 amRNSTransaction in Own Shares
3rd Aug 20225:45 pmRNSTransaction in Own Shares
2nd Aug 20223:45 pmRNSTransaction in Own Shares
29th Jul 20229:30 amRNSTransaction in Own Shares
26th Jul 20226:24 pmRNSTransaction in Own Shares
19th Jul 20224:00 pmRNSHolding(s) in Company
19th Jul 20223:00 pmRNSTransaction in Own Shares
18th Jul 20224:30 pmRNSTransaction in Own Shares
15th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20227:00 amRNSShare Buyback Programme
12th Jul 20227:00 amRNSQuarterly Trading Update
12th Jul 20227:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2022
30th Jun 20224:15 pmRNSHolding(s) in Company
30th Jun 20229:30 amRNSHolding(s) in Company
27th Jun 20223:00 pmRNSDirectorate Change
22nd Jun 20227:00 amRNSDistribution policy
6th Jun 20227:00 amRNSHolding(s) in Company
26th May 20221:15 pmRNSDirectorate Change
13th May 202212:15 pmRNSChange of Registered Office
27th Apr 20227:00 amRNSTrading Update
1st Apr 20222:00 pmRNSCompletion of Share Buyback Programme
25th Mar 20225:21 pmRNSTransaction in Own Shares
23rd Mar 20223:30 pmRNSTransaction in Own Shares
22nd Mar 20225:32 pmRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSUpdate re Stefan Barden
11th Mar 20226:00 pmRNSTransaction in Own Shares
11th Mar 20223:30 pmRNSHolding(s) in Company
4th Mar 20226:25 pmRNSTransaction in Own Shares
4th Mar 202210:15 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20224:15 pmRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTrading Update
21st Feb 20223:15 pmRNSTransaction in Own Shares
18th Feb 20225:31 pmRNSTransaction in Own Shares
16th Feb 20225:30 pmRNSTransaction in Own Shares
15th Feb 202210:15 amRNSTransaction in Own Shares
14th Feb 20225:02 pmRNSTransaction in Own Shares
11th Feb 20225:15 pmRNSTransaction in Own Shares
9th Feb 20223:45 pmRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTrading Update
4th Feb 202211:45 amRNSHolding(s) in Company
24th Jan 20225:50 pmRNSTransaction in Own Shares
21st Jan 20225:15 pmRNSTransaction in Own Shares
20th Jan 20225:15 pmRNSTransaction in Own Shares
12th Jan 202212:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.